October 31, 2019
Quacell Biotechnology won the Top 50 of Innovative Biotechnology Enterprises in Guangdong-Hong Kong-Macau Greater Bay Area
On October 16th, in Guangzhou, the 2nd Edition Guangdong-Hong Kong-Macau Greater Bay Area Biotechnology Innovation Development Summit & Award Ceremony of Top 50 Biotechnology Innovation Enterprises in Guangdong-Hong Kong-Macau Greater Bay Area awarded Quacell Technology the honor of Potential Enterprise.
Sponsored by KPMG China and the CIC Research Institute, this selection event aimed to discover unicorn companies in the Biotechnology Industry and cultivate an innovative ecology integrating production, education, and research in Guangdong-Hong Kong-Macau Greater Bay Area.
Adopting the Big Data Innovation Standard System, the selection focused on three significant companies: Medical Devices, Biomedicine and Technology, and Medical Services. To select Leading Enterprise, Pioneer Enterprise, New enterprises, and Potential enterprises, leading teams of experts spent six months to conduct field visits and have face-to-face discussions with companies in Guangdong-Hong Kong-Macau Greater Bay Area.
Drug Master Files are available for the QuaCell® CHO cell culture mediums, facilitating applications for antibody drugs
QuaCell Biotechnology launched its Innovation Research Center in Guangzhou